These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9520130

  • 1. LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients.
    Kronenberg F, Trenkwalder E, Sturm W, Kathrein H, König P, Neyer U, Gröchenig E, Utermann G, Dieplinger H.
    Clin Genet; 1997 Nov; 52(5):377-86. PubMed ID: 9520130
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.
    Kronenberg F, Kathrein H, König P, Neyer U, Sturm W, Lhotta K, Gröchenig E, Utermann G, Dieplinger H.
    Arterioscler Thromb; 1994 Sep; 14(9):1405-11. PubMed ID: 8068600
    [Abstract] [Full Text] [Related]

  • 3. Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease.
    Trenkwalder E, Gruber A, König P, Dieplinger H, Kronenberg F.
    Kidney Int; 1997 Dec; 52(6):1685-92. PubMed ID: 9407518
    [Abstract] [Full Text] [Related]

  • 4. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.
    Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T.
    Kidney Int; 1999 May; 55(5):1899-911. PubMed ID: 10231453
    [Abstract] [Full Text] [Related]

  • 5. High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay.
    Mooser V, Marcovina SM, Wang J, Hobbs HH.
    Clin Genet; 1997 Nov; 52(5):387-92. PubMed ID: 9520131
    [Abstract] [Full Text] [Related]

  • 6. Lipoprotein(a) in renal disease.
    Kronenberg F, Utermann G, Dieplinger H.
    Am J Kidney Dis; 1996 Jan; 27(1):1-25. PubMed ID: 8546123
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.
    Güz G, Nurhan Ozdemir F, Sezer S, Işiklar I, Arat Z, Turan M, Haberal M.
    Am J Kidney Dis; 2000 Oct; 36(4):826-36. PubMed ID: 11007687
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.
    Jürgens G, Taddei-Peters WC, Költringer P, Petek W, Chen Q, Greilberger J, Macomber PF, Butman BT, Stead AG, Ransom JH.
    Stroke; 1995 Oct; 26(10):1841-8. PubMed ID: 7570736
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of serum apolipoprotein A-IV as a marker of cardiovascular disease in maintenance hemodialysis patients.
    Omori M, Watanabe M, Matsumoto K, Honda H, Hattori H, Akizawa T.
    Ther Apher Dial; 2010 Jun; 14(3):341-8. PubMed ID: 20609189
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006 Jun; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.